F

FZata, Inc.

9 employees

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

microbiota

Biologics

Therapeutics

Antibodies

Medical

Pharmaceutical

Gastrointestinal

Nanobodies

Date founded

2015

FAQ